Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy, Safety and Mechanism of High Definition Transcranial Direct Current Stimulation (HD-tDCS) in the Treatment of Refractory Epilepsy

NCT06241963 is registered in ClinicalTrials.gov with Anhui Medical University as lead sponsor.

NCT NCT06241963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06241963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy, Safety and Mechanism of High Definition Transcranial Direct Current Stimulation (HD-tDCS) in the Treatment of Refractory Epilepsy
Lead sponsor
Anhui Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
February 12, 2024
Completion date
June 30, 2026
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eeg, functional magnetic resonance imaging, refractory epilepsy, transcranial direct current stimulation, transcranial magnetic stimulation